Carl L Gordon is of Adicet Bio, Inc.. Currently has a direct ownership of 11,800 shares of ACET, which is worth approximately $16,638. The most recent transaction as insider was on Jun 05, 2024, when has been sold 5,900 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 11.8K
0% 3M change
100.0% 12M change
Total Value Held $16,638

CARL L GORDON Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 05 2024
BUY
Grant, award, or other acquisition
-
5,900 Added 33.33%
11,800 Common Stock
Jun 01 2023
BUY
Grant, award, or other acquisition
-
5,900 Added 50.0%
5,900 Common Stock

Also insider at

TPTX
Turning Point Therapeutics, Inc.
KNTE
Kinnate Biopharma Inc. Healthcare
PRVL
Prevail Therapeutics Inc.
TERN
Terns Pharmaceuticals, Inc. Healthcare
ORIC
Oric Pharmaceuticals, Inc. Healthcare
KROS
Keros Therapeutics, Inc. Healthcare
GMTX
Gemini Therapeutics, Inc. Healthcare
THRX
Theseus Pharmaceuticals, Inc. Healthcare
CMPX
Compass Therapeutics, Inc. Healthcare
AVBP
ArriVent Biopharma, Inc.
MBX
MBX Biosciences, Inc.
CLG

Carl L Gordon

San Diego, CA

Track Institutional and Insider Activities on ACET

Follow Adicet Bio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACET shares.

Notify only if

Insider Trading

Get notified when an Adicet Bio, Inc. insider buys or sells ACET shares.

Notify only if

News

Receive news related to Adicet Bio, Inc.

Track Activities on ACET